SCHEDULE: Vanguard Group Updates RxSight Ownership Reporting

The Vanguard Group filed an amended Schedule 13G for RxSight Inc, reporting 0% beneficial ownership due to an internal reporting realignment.

Summary

• The Vanguard Group filed an Amendment No. 2 to its Schedule 13G for RxSight Inc, concerning its Common Stock (CUSIP: 78349D107).
• The filing reports 0% beneficial ownership of RxSight Inc's Common Stock by The Vanguard Group, with no sole or shared voting or dispositive power.
• This change is a result of an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The subsidiaries and/or business divisions continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update. It reflects an internal reporting change by The Vanguard Group and does not indicate any change in the underlying investment position or operational status of RxSight Inc.

Future Outlook

This administrative filing does not provide any forward-looking statements or guidance regarding RxSight Inc's operations or financial performance.

Management Comments

• The Vanguard Group, Inc. went through an internal realignment on January 12, 2026.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically used by passive investors, such as mutual funds or institutional investors, to report beneficial ownership of 5% or more of a company's stock. An amendment like this, reporting 0% ownership by the parent entity due to internal realignment, indicates a change in reporting structure rather than a divestment of shares by the underlying funds. This is a common administrative adjustment for large asset managers like Vanguard to comply with SEC regulations regarding disaggregated reporting.

Stakeholder Impact

• Shareholders of RxSight Inc: Minimal direct impact, as the underlying beneficial ownership by Vanguard's managed funds is not necessarily changed, only the reporting entity.
• The Vanguard Group: This reflects an internal administrative change in reporting structure to comply with SEC guidelines.

Key Dates

Keywords

Schedule 13G, beneficial ownership, Vanguard Group, RxSight Inc, SEC filing, institutional ownership, reporting realignment